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Abstract
Background: Past studies in India included only symptomatic pregnant women and thus may have overestimated the
proportion of women with malaria. Given the large population at risk, a cross sectional study was conducted in order to
better define the burden of malaria in pregnancy in Jharkhand, a malaria-endemic state in central-east India.
Methods: Cross-sectional surveys at antenatal clinics and delivery units were performed over a 12-month period at two
district hospitals in urban and semi-urban areas, and a rural mission hospital. Malaria was diagnosed by Giemsa-stained
blood smear and/or rapid diagnostic test using peripheral or placental blood.
Results: 2,386 pregnant women were enrolled at the antenatal clinics and 718 at the delivery units. 1.8% (43/2382) of
the antenatal clinic cohort had a positive diagnostic test for malaria (53.5% Plasmodium falciparum, 37.2% Plasmodium vivax,
and 9.3% mixed infections). Peripheral parasitaemia was more common in pregnant women attending antenatal clinics in
rural sites (adjusted relative risk [aRR] 4.31, 95%CI 1.84-10.11) and in those who were younger than 20 years (aRR 2.68,
95%CI 1.03-6.98). Among delivery unit participants, 1.7% (12/717) had peripheral parasitaemia and 2.4% (17/712) had
placental parasitaemia. Women attending delivery units were more likely to be parasitaemic if they were in their first or
second pregnancy (aRR 3.17, 95%CI 1.32-7.61), had fever in the last week (aRR 5.34, 95%CI 2.89-9.90), or had rural
residence (aRR 3.10, 95%CI 1.66-5.79). Malaria control measures including indoor residual spraying (IRS) and untreated
bed nets were common, whereas insecticide-treated bed nets (ITN) and malaria chemoprophylaxis were rarely used.
Conclusion: The prevalence of malaria among pregnant women was relatively low. However, given the large at-risk
population in this malaria-endemic region of India, there is a need to enhance ITN availability and use for prevention of
malaria in pregnancy, and to improve case management of symptomatic pregnant women.
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Background
Malaria is a disease of global importance that results in
300-660 million cases annually and an estimated 2.2 bil-
lion people at risk of infection [1]. Approximately 2.5 mil-
lion malaria cases are reported annually from South Asia,
of which 76% are reported in India [2,3]. Malaria is
endemic throughout India with 95% of the population at
risk of infection [4]. Infections caused by Plasmodium fal-
ciparum have increased in India in recent years [2,5].
Malaria in pregnancy (MIP) poses substantial risk to the
mother, foetus and neonate. In settings with either stable
or unstable transmission, MIP has serious public health
consequences. In areas of stable malaria transmission,
clinically symptomatic infections are rare and the main
consequence is an increased risk of maternal anaemia
[6,7] low birth weight (LBW) infants [8] and infant deaths
[9]. In areas with low or unstable malaria transmission,
pregnant women have little acquired immunity to malaria
and are, therefore, at increased risk of symptomatic
malaria, severe malaria with central nervous system com-
plications, anaemia, and adverse birth outcomes, such as
abortion, preterm labor and stillbirths [10,11].
Past MIP studies in India have demonstrated the impor-
tant contribution of malaria to maternal and neonatal
morbidity and mortality [4,12]. Although preliminary
results from earlier studies carried out in central India sug-
gest that both P. falciparum and P. vivax are associated with
adverse pregnancy outcomes, these studies primarily
focused on symptomatic pregnant women [12,13]. Rela-
tively little information is available from India about pla-
cental malaria, which is associated with an increased risk
of neonatal and infant mortality [11,14]. Given the lim-
ited information on asymptomatic malaria and placental
malaria in India, this study was undertaken in order to
better define the burden of MIP, the prevalence of asymp-
tomatic malaria, and the relative contribution of P. falci-
parum and P. vivax during pregnancy and at delivery. The
study was conducted in the state of Jharkhand in east
India, with the ultimate goal of enhancing the develop-
ment of evidence-based policies to reduce the burden of
disease due to MIP in this region of India.
Methods
Study site/design
This study consisted of a series of cross-sectional surveys
conducted in three hospitals (Sadar, Civil and Ursula Mis-
sion) in two districts in Jharkhand, India (Figure 1).
Jharkhand had a yearly average slide positivity rate (SPR)
for symptomatic individuals of 6.8% over the last three
years with P. falciparum accounting for 44% of the cases
[15]. The Jharkhand State Vector Borne Disease Control
Programme benefited from the Enhanced Malaria Control
Project (EMCP) funded by the World Bank from 1997 to
2005 [16,17]. Most districts, including the two study dis-
tricts described below, were targeted by this project, which
included vector control with larvicides and indoor resid-
ual spraying (IRS) with dichloro-diphenyl-trichlo-
roethane (DDT) or synthetic pyrethroids; distribution of
insecticide-treated bed nets (ITN); and early case detec-
tion and prompt treatment of malaria (any species) with
chloroquine and primaquine (chloroquine alone for
pregnant women).
The two rural study sites were selected in the district of
Gumla (total population as of 2005 was 684,383), which
at the time of the study, was considered to be a malaria-
endemic area of the state of Jharkhand. In contrast, the
third site, Ranchi District (total population as of 2005 was
1,258,306), was selected to represent an urban district
with low transmission of malaria. Thus, the three sites
were meant to provide a reasonable representation of typ-
ical conditions that would be found in Jharkhand. The
District Level Household and Facility Survey conducted
between December 2007 and April 2008 revealed that
56% of women had at least one antenatal clinic (ANC)
visit and 18% overall had institutional deliveries includ-
ing 59% in urban areas but only 13% in rural settings[18]
Sadar Hospital, the district hospital for Ranchi District,
serves a predominantly urban population and has a sepa-
rate obstetric unit with 30 beds, with a high volume of
annual deliveries ranging from an average of 2500 to 3000
per year in 2005 to 2008. The Sadar Hospital also has a
high volume of ANC visits including an average of 3200
to 3600 per year from 2005 to 2008. Civil Hospital, the
district hospital for Gumla District, is a 40-bed hospital
serving a semi-urban population, which has 2,000 ANC
visits and about 1,000 deliveries annually. The Ursula
Mission Hospital, situated in Konbir in Gumla District,
serves a predominantly rural population and has 1200
ANC visits and about 300 deliveries each year.
The SPR in Ranchi District was 7.2% in 2005 [15]. IRS in
Ranchi is primarily done with DDT. The SPR in Gumla
District in 2005 was 3.4% but had been substantially
higher in the recent past, ranging from as low as 10% to as
high as 19.7% between 1997 and 2003 [15]. The IRS pro-
gramme in Gumla uses synthetic pyrethroids. Konbir is
situated close to the border of Simdega, a highly malari-
ous district with a SPR of 14% in 2005.
Screening and enrollment
The study had three components with recruitment tar-
geted to women presenting to ANC, delivery units (DU),
or the inpatient antepartum ward. For the ANC compo-
nent, pregnant women aged ≥15 years who reported to the
study site for routine care were screened and enrolled.
Those who had previously participated in this component
of the study or were unwilling to provide writtenMalaria Journal 2009, 8:210 http://www.malariajournal.com/content/8/1/210
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informed consent were excluded. For the DU component,
women aged ≥15 years who presented for delivery and
were willing to provide written informed consent were
enrolled. For inpatients, pregnant women with an admis-
sion diagnosis of malaria, anaemia, or a febrile illness of
unknown origin were screened for study participation.
Those whose malaria-related diagnosis was confirmed or
who were treated for malaria were enrolled after obtaining
informed consent. Case report forms and study proce-
dures were evaluated in a pilot study and modified
accordingly.
ANC procedures
Trained study personnel interviewed the enrolled women
and collected information on socio-demographic charac-
teristics (i.e., date of birth, socio-economic status, liter-
acy); reproductive history including gravidity; history of
fever and anti-malarial drug use; and use of anti-malarial
prevention measures. A complete physical examination
including the determination of gestational age from the
height of fundus, measurement of axillary temperature
with digital thermometer, and other vital signs was also
performed. Blood was obtained by finger-stick for malaria
blood film preparation, rapid diagnostic test (RDT), and
haemoglobin determination. Women with positive RDT
results or who were anemic were referred immediately to
the hospital physician for treatment. The clinic staff was
informed of additional parasitaemic individuals identi-
fied through blood smears so that they could be appropri-
ately treated.
DU procedures
Pregnant women enrolled at the DUs were interviewed,
with data collection focused on socio-demographic char-
acteristics, obstetric complications, history of fever and
anti-malarial use during pregnancy, and the use of anti-
malarial prevention measures. Blood was obtained by fin-
ger-stick soon after delivery for haemoglobin determina-
tion, RDT, and malaria blood film preparation. Placental
blood by aspiration and an impression smear from the
maternal side of the placenta were obtained to determine
placental parasitaemia by thick smears and RDT. A drop
of cord blood was also taken to prepare a blood smear. All
neonates were weighed with an electronic digital scale to
Map of Jharkhand with study sites Figure 1
Map of Jharkhand with study sites.
Site 1:
Ranchi  Site 2: 
Gumla
Site 3: 
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the nearest 10 grams and the gestational ages of all live
births were estimated within 24 hours of delivery by
means of a modified Ballard examination [19]. Women
with positive RDT or blood smear results were referred for
treatment.
Inpatient procedures
Enrolled subjects were interviewed and information on
socio-economic status, reproductive history including
obstetric history, history of fever and anti-malarial drug
use, and the use of anti-malarial prevention measures was
collected. Data including recorded clinical signs, results of
laboratory investigations, treatments administered,
admission and discharge diagnosis and outcome of
admission were extracted from the subject's hospital
record.
Laboratory procedures
Thick and thin smears prepared from peripheral blood of
ANC and DU subjects, placental blood and placental
impression from DU subjects, and cord blood were
Giemsa-stained and examined under high power. Asexual
parasite forms were counted until a minimum of 200
white cells had been counted. Slides were considered neg-
ative only if no parasites were seen after identifying 500
leukocytes. Parasite densities were estimated using an
assumed total white blood cell count of 8,000 leukocytes/
μL of blood [20]. The thin film was used to identify the
Plasmodium species. All smears were re-checked by a mem-
ber of the parasitology laboratory at the National Institute
of Malaria Research Field Station in Jabalpur. The First
Response Malaria Pf/Pv test (PMC, Mumbai, India), a par-
asite lactic dehydrogenase antigen test, was used to per-
form the RDTs. This test has a sensitivity of 93% and
specificity of 85% for detection of malaria in non-preg-
nant individuals [21]. The First Response Malaria Pf/Pv
test has also been evaluated as a screening tool in preg-
nant women. Compared to expert microscopy, this test
had a sensitivity and specificity of 95% and 99.6% for P.
falciparum and 69% and 99.4% for P. vivax, respectively
[22]. A portable HemoCue machine (Ängelholm, Swe-
den), using a control with each assay, was used for haemo-
globin determinations.
Study definitions
The following definitions were used:
Peripheral parasitaemia: presence of asexual P. falciparum
or P. vivax parasitic forms on blood smears or positive
RDT.
Placental malaria: presence of malaria parasites on
impression smear of maternal side of placenta or by RDT.
Symptomatic malaria infection: history of fever within the
last week or temperature ≥ 37.5°C associated with the
presence of asexual forms of P. falciparum or P. vivax on
thick blood smear or a positive RDT.
Severe malaria: a malaria attack associated with any of the
following: cerebral malaria, severe anaemia, renal failure,
pulmonary oedema, hypoglycaemia, shock, spontaneous
bleeding, or repeated convulsions[23]
Anaemia: haemoglobin <110 g/L.
Severe anaemia: haemoglobin <70 g/L.
Low birth weight: birth weight < 2,500 g.
Prematurity: gestational age <37 weeks as assessed by Bal-
lard examination [19].
Stillbirth: death of foetus prior to delivery.
Ethical clearance
The study was approved by the Institutional Review
Boards of Boston University and the Centers for Disease
Control and Prevention, the Ethics Committee of the
National Institute of Malaria Research (NIMR) in India,
the Scientific Advisory Committee of the NIMR and the
Health Ministry Screening Committee of the Indian
Council of Medical Research.
Data management and analysis
All case report forms were checked for completeness and
inappropriate or illogical responses. The forms were dou-
ble-entered using CS-Pro, with range, consistency, and
edit checks built into the data entry programme for qual-
ity control. The two databases were validated and all
inconsistencies and differences were resolved. Statistical
analyses were performed using SAS software version 9.1
(Cary, North Carolina). Categorical data are presented as
frequency counts (percent) and compared using the chi-
square or Fisher's exact statistic as appropriate. Continu-
ous data are presented as means (± standard deviation)
and compared using the t-test or analysis of variance as
appropriate. Since most participants did not know their
exact date of birth, we have presented participants' ages in
ranges based on their estimations. Risk factors for either P.
falciparum or P. vivax parasitaemia were evaluated by uni-
variate analysis and then adjusted for significant predic-
tors in multivariate analysis.
Results
Recruitment and enrollment took place from December
2006 to December 2007. Of 2499 pregnant women
screened during their ANC visits, 60 were not eligible
because they had previously participated in the study, 53
refused to provide informed consent, and 2,386 were
enrolled. In the DU, 739 pregnant women were screenedMalaria Journal 2009, 8:210 http://www.malariajournal.com/content/8/1/210
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and all of them were eligible, although 21 refused to pro-
vide consent and therefore 718 were enrolled.
Antenatal clinics
Most pregnant women attending ANC were in the 20 to
34 year old age range and had some level of formal edu-
cation (Table 1). The vast majority of participants were
Hindi speaking (99.4%) and non-smoking (99.9%). Most
owned their own home (73.4%) and were engaged in
household work (76.7%) with a small proportion
involved in farming (10.7%). They had attended a
median of one ANC visit (range 0-9) during their current
pregnancy and slightly more than a third were primigravi-
dae. Slightly more than half of participants presented to
the ANC in the latter half of pregnancy whereas 46.3%
presented prior to 20 weeks. Less than half of the partici-
pants reported taking iron/folate supplements (39.6%)
while 27.3% were taking multivitamins. In terms of
malaria prevention activities, most pregnant women
reported having untreated bed nets in their homes, and
Table 1: Baseline characteristics of pregnant women attending antenatal clinics and delivery units
Characteristic Antenatal clinics
n = 2386
Delivery units
n = 718
n† (%) n† (%)
Age (years)
<20 305 (12.8%) 67 (9.3%)
20-34 1,978 (82.9%) 614 (85.5%)
≥35 103 (4.3%) 37 (5.2%)
Prior pregnancies
Primigravid 875 (36.7%) 306 (42.6%)
Secundigravid 628 (26.3%) 174 (24.2%)
Multigravid* 882 (37.0%) 238 (33.2%)
Gestational age at enrollment (weeks)**
< 20 weeks 1,104 (46.3%) n/a
20-36 weeks 1,239 (51.9%) 42 (7.1%)
≥ 37 weeks 43 (1.8%) 637 (92.9%)
Caste
Schedule caste 234 (9.8%) 74 (10.3%)
General caste 678 (28.4%) 189 (26.3%)
Other backward caste 683 (28.7%) 192 (26.8%)
Scheduled tribal 789 (33.1%) 263 (36.6%)
Education
No formal schooling 621 (26.0%) 217 (30.2%)
Attended school any length of time 1,764 (74.0%) 501 (69.8%)
Socioeconomic characteristics
Owns TV 1,196 (50.1%) 293 (40.8%)
Owns bicycle 1,635 (68.5%) 512 (71.3%)
Owns house 1,751 (73.4%) 585 (81.5%)
Owns refrigerator 104 (4.4%) 16 (2.2%)
Roof material
Mud 1,317 (55.2%) 482 (67.1%)
Corrugated iron/asbestos sheet 699 (29.3%) 149 (20.8%)
Cement/concrete 350 (14.7%) 82 (11.4%)
Other 20 (0.8%) 5 (0.7%)
Wall material
Mud/sand/dung 1,193 (50.0%) 452 (63.0%)
Mud bricks 131 (5.5%) 33 (4.6%)
Cement bricks 1,008 (42.2%) 212 (29.5%)
Other 54 (2.3%) 21 (2.9%)
Primary cooking fuel
Wood 1,428 (59.9%) 502 (69.9%)
Charcoal 441 (18.5%) 107 (14.9%)
Gas 480 (20.1%) 95 (13.2%)
Other 37 (1.5%) 14 (2.0%)
† Numbers may not add to sample size secondary to missing data.
* Defined as 3 or more pregnancies
** For ANC enrollees, gestational age assessed by fundal height. For DU enrollees, gestational age was assessed by Ballard score. Infants that were 
stillborn did not have a Ballard examination performed.Malaria Journal 2009, 8:210 http://www.malariajournal.com/content/8/1/210
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using them recently, but very few had ITNs (Table 2). Sim-
ilarly, only 14 of the women were taking prophylaxis for
malaria and most of them (10/14, 71%) were unable to
identify the drug they were taking. Of those who were able
to identify the drug they were using, 75% (3/4) were tak-
ing chloroquine.
A positive diagnostic test for malaria was obtained in
1.8% (43/2382) of the total cohort (Table 3). Peripheral
smears were not performed for four pregnant women.
Blood smears for malaria were positive in 1.3% of preg-
nant women while an additional 11 (0.5%) women had
positive RDTs. The mean density of parasitaemia in the 32
women with positive blood smears was 57,145 asexual
forms/μL (range 200-376,000). P. falciparum was identi-
fied in 53.5% of parasitemic individuals while P. vivax was
found in 37.2% and 9.3% of infections were mixed.
Peripheral parasitaemia was over three times more likely
among women living in rural areas when compared with
those from urban or semi-urban sites (OR 3.45, 95% CI
1.88-6.32), and among primigravidae and secundigravi-
dae relative to multigravidae (OR 3.69, 95%CI 1.55-
8.77). Primigravidae had higher parasite densities than
women with one or more past pregnancies but this differ-
ence was not statistically significant (mean ± SD of 70,034
± 107,625 vs. 16,090 ± 66,883 asexual forms/μL, respec-
tively, p = 0.47). Parasitaemia was more commonly
encountered in pregnant women who had a history of
fever within the week prior to enrollment or were febrile
at the time of the study visit (5.5% vs. 1.1%, p < 0.001).
Overall 51.2% (22/43) of the pregnant women with a
positive malaria diagnostic test at the time of ANC visit
were symptomatic. The majority of positive malaria tests
occurred from April to December with the greatest
number in July, corresponding to the monsoon season.
Anaemia was common among ANC participants whereas
severe anaemia was rare (Table 3). Anaemia was not asso-
ciated with malaria (p = 0.77); however, severe anaemia
was more common among women with parasitaemia (p
= 0.023).
Multivariate analysis was performed in order to identify
the association between specific demographic, socioeco-
nomic, and malaria prevention activities and the risk of
parasitaemia. Among pregnant women attending ANCs,
first/second pregnancies, fever in the past week, and resi-
dence in rural areas were significantly associated with
peripheral parasitaemia (Table 4).
Delivery units
Like the ANC cohort, most pregnant women attending
DUs were aged 20-34 years and had some level of formal
education (Table 1). All were non-smokers (100%) and
nearly all spoke Hindi (99.4%). Most owned their own
home (81.5%) and were involved in household work
(76.6%); a minority engaged in farming (11.1%). Study
participants had attended a median of two ANC visits
(range 0-9) and about two-thirds were primigravidae and
secundigravidae (Table 1). The majority of pregnant
women reported having untreated bed nets in their homes
and using them recently but ITN ownership was rare
(Table 2). Only two women were taking chemoprophy-
laxis for malaria and neither knew the name of the medi-
cation that they were taking.
Only 1.7% of the women enrolled at the DUs had periph-
eral parasitaemia (either a positive blood smear and/or
RDT).P. falciparum was identified in 75% (9/12), P. vivax
in 17% (2/12), and mixed infection in 8% (1/12). The
mean density of parasitaemia in the women with positive
blood smears was 14,272 asexual forms/μL (range 280-
42,000). The peripheral parasitaemia density was signifi-
cantly higher for primigravid women than in those who
had one or more prior pregnancies (mean ± SD of 22,800
± 10,866 vs. 5,744 ± 5847 asexual forms/μL, respectively;
p = 0.02). A greater proportion of the women presenting
to the semi-urban and rural sites were parasitaemic but
this difference was not significant (OR 2.78, 95%CI 0.61-
12.8) (Table 3). Primigravidae and secundigravidae also
were more likely to be parasitaemic, but this difference
was not significant (OR 5.57, 95% CI 0.72-43.4). Multi-
variate analysis revealed a significant association between
placental or peripheral parasitaemia and age less than 20
years and fever within the last week (Table 5).
Placental impression yielded one more case (10/712,
1.4%) than placental blood smears (9/712, 1.3%). The
Table 2: Use of malaria prevention measures by pregnant women attending antenatal clinics and delivery units
Prevention measures utilized Antenatal clinics
n = 2386
n, (%)
Delivery units
n = 718
n, (%)
Bed net in household 2,055 (86.2%) 597 (83.3%)
Insecticide-treated bed net in household 79 (3.3%) 22 (3.1%)
Sleeps under bed net most nights 1,702 (82.8%) 439 (73.7%)
Taken malaria prophylaxis in pregnancy 14 (0.6%) 2 (0.3%)
Indoor residual spraying of home with insecticide 1270 (53.5%) 418 (58.5%)Malaria Journal 2009, 8:210 http://www.malariajournal.com/content/8/1/210
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mean density of placental parasitaemia in the 10 women
with positive smears was 13,200 asexual forms/μL (range
240- 42,000). An additional seven cases of placental par-
asitaemia were identified by RDT yielding an overall prev-
alence of placental parasitaemia of 2.4% with non-
significantly greater proportions seen at the non-urban
sites and in primigravidae and secundigravidae. Sympto-
matic malaria infections were present in 42% of women
with peripheral parasitaemia (5/12) and 41% of those
with placental parasitaemia (7/17). Pregnant women with
peripheral parasitaemia were more likely to have either a
self-reported fever or fever measured at enrollment than
those who were aparasitaemic (41.7% vs 11.3%, p =
0.008). Similarly, more women with placental parasitae-
mia had fever (reported or measured) compared with
women whose placentas did not harbour parasites
(41.2% vs. 11.0% p = 0.002). As observed in the ANC par-
ticipants, most episodes of parasitaemia occurred in July
and August during the monsoon season.
More than half of the DU participants were anemic but
only 4.5% had severe anaemia (Table 3). For DU partici-
pants with peripheral parasitaemia, 100% had anaemia as
compared to 58.9% of those who did not have parasitae-
mia (p = 0.002). More women with peripheral parasitae-
mia had severe anaemia (8.3%) than those without
parasitaemia (4.4%) but the difference was not significant
(p = 0.43).
Excluding the 6 sets of twins delivered, 20.9% (141/675)
of the babies delivered by the DU participants had LBW.
There were slightly more LBW infants among mothers
with placental malaria, but this difference was not signifi-
cant (p = 0.53) (Table 6). The overall prevalence of pre-
term delivery by Ballard score in the DU participants was
5.8% (39/674) and was non-significantly (p = 0.22)
higher in the women with placental parasitaemia. Among
the participants with placental malaria, the prevalence of
stillbirth was more than twice as frequent in those without
Table 3: Parasitaemia, reported fever, and anaemia among pregnant women attending antenatal clinics and delivery units
Antenatal Clinics Delivery Units
n (%) n (%)
Peripheral parasitaemia¶
Overall 43/2,382 (1.8%) 12/717 (1.7%)
Falciparum 23/2,382 (1.0%) 9/717 (1.3%)
Vivax 16/2,382 (0.7%) 2/717 (0.3%)
Mixed 4/2,382 (0.2%) 1/717 (0.14%)
By site
Urban (Ranchi) 7/935 (0.8%) 2/254 (0.8%)
Semiurban (Gumla) 15/907 (1.6%) 4/183 (2.2%)
Rural (Konubir) 21/525 (4.0%) 6/280 (2.1%)
By gravidity 19/875 (2.2%) 6/306 (2.0%)
Primigravid 18/628 (2.9%) 5/173 (2.9%)
Secundigravid 6/882 (0.7%) 1/238 (0.4%)
Multigravid**
Placental parasitaemia
Overall n/a 17/712 (2.4%)
Falciparum 12/712 (1.7%)
Vivax 2/712 (0.3%)
Mixed 3/712 (0.4%)
By site n/a
Urban (Ranchi) 2/252 (0.8%)
Semiurban (Gumla) 5/181 (2.8%)
Rural (Konubir) 10/279 (3.6%)
By gravidity n/a
Primigravid 9/303 (3.0%)
Secundigravid 5/172 (2.9%)
Multigravid 3/237 (1.3%)
Cord blood parasitaemia n/a 6/562 (1.1%)
Report of fever within 1 week 400/2,384 (16.8%) 78/715 (10.9%)
Anaemia 1,722/2,378 (72.4%) 424/711 (59.6%)
Severe anaemia 92/2,378 (3.9%) 32/711 (4.5%)
¶Parasitaemia defined by presence of parasites on blood or tissue impression smear or by positive RDT.
*ANC: Peripheral blood smears not obtained for 4 women. DU: peripheral blood smears not obtained for 1 woman. Placental blood not obtained 
for 6 women.
*Defined as 3 or more pregnancies
NA = not applicableMalaria Journal 2009, 8:210 http://www.malariajournal.com/content/8/1/210
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Table 4: Univariate and multivariate analysis of predictors of peripheral parasitaemia among pregnant women attending antenatal 
clinics
Univariate Analysis Multivariate Analysis
Peripheral Parasitaemia
% (Positive/Total)
Relative Risk (95% CI) Adjusted¶
Relative Risk (95% CI)
First/second pregnancies 2.5% (37/1503) 3.62 (1.53 - 8.54) 3.17 (1.32-7.61)
Third or greater pregnancy 0.7% (6/882) 1
Age < 20 2.0% (6/305) 1.11 (0.47 - 2.60)
Age ≥ 20 1.8% (37/2081) 1
Fever within past week 5.5% (22/401) 5.19 (2.88 - 9.34) 5.34(2.89-9.90)
No fever within past week 1.1% (21/1985) 1
Bednet use* 1.8% (31/1702) 1.29 (0.50 - 3.29)
No bednet use 1.4% (5/354) 1
Indoor residual spraying 1.8% (23/1270) 1.00 (0.55 - 1.81)
No indoor residual spraying 1.8% (20/1104) 1
Rural 4.0% (21/527) 3.37 (1.87 - 6.07) 3.10(1.66-5.79)
Not rural 1.2% (22/1859) 1
Tribal caste 2.8% (22/789) 2.12 (1.17 - 3.83) 1.67 (0.90-3.11)
Not tribal caste 1.3% (21/1595) 1
No formal education 1.3% (8/621) 0.65 (0.30 - 1.39)
Formal education 2.0% (35/1764) 1
Homeowner 1.9% (34/1751) 1.37 (0.66 - 2.84)
Not homeowner 1.4% (9/635) 1
Mud walls 2.3% (30/1324) 1.85 (0.97 - 3.53)
No mud walls 1.2% (13/1062) 1
¶Risk ratio adjusted for first/second pregnancies, fever within past week, rural locale, and tribal caste.
* ITN use was not evaluated in this model since these were very rarely used.
Table 5: Univariate and multivariate analysis of predictors of peripheral parasitaemia among women attending delivery units
Univariate Analysis Multivariate Analysis
Peripheral Parasitaemia
% (Positive/Total)
Relative Risk (95% CI) Adjusted¶
Relative Risk (95% CI)
First/second pregnancies 3.8% (18/475) 2.99 (0.89 - 10.06)
Third or greater pregnancy 1.3% (3/237) 1
Age <20 7.6% (5/66) 3.06 (1.16 - 8.08) 2.68 (1.03 - 6.98)
Age ≥ 20 2.5% (16/646) 1
Fever within past week 9.6% (8/83) 4.64 (1.98 - 10.86) 4.31 (1.84 - 10.11)
No fever within past week 2.1% (13/626) 1
Bednet use* 3.0% (13/437) 1.54 (0.44 - 5.32)
No bednet use 1.9% (3/155) 1
Indoor residual spraying 3.9% (16/415) 2.26 (0.84 - 6.10)
No indoor residual spraying 1.7% (5/293) 1
Rural 3.9% (11/279) 1.71 (0.73 - 3.97)
Not rural 2.3% (10/433) 1
Tribal caste 3.1% (8/260) 1.07 (0.45 - 2.55)
Not tribal caste 2.9% (13/452) 1
No formal education 2.8% (6/217) 0.91 (0.36 - 2.32)
Formal education 3.0% (15/495) 1
Homeowner 3.5% (20/579) 4.59 (0.62 - 33.93)
Not homeowner 0.8% (1/133) 1
Mud walls 3.8% (18/480) 2.90 (0.86 - 9.75)
No mud walls 1.3% (3/232) 1
†Risk ratio adjusted for fever within past week and age less than 20.
* ITN use was not evaluated in this model since these were very rarely used.Malaria Journal 2009, 8:210 http://www.malariajournal.com/content/8/1/210
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placental malaria but due to the low rates of infection, this
difference was not significant (p = 0.16).
In-patients
Twenty-seven pregnant women who were admitted and
treated for malaria according to national guidelines in the
three hospitals were enrolled. They represented 19.2% of
pregnant women admitted for any medical treatment
other than deliveries during the twelve-month study
period. The majority (82%) of the inpatients were
between 20 and 34 years old (82%). Six (22%) were prim-
igravidae, 10 (37%) secundigravidae, and 11 (41%) mul-
tigravidae. The majority was from scheduled tribes (59%)
with the others belonging to general caste (19%), sched-
uled caste (11%) and other backward castes (11%). Simi-
lar to the ANC and DU participants, 78% reported having
a bed net in the household and 63% reported sleeping
under it most nights although only 7.4% were insecticide-
treated. Sixty-seven percent of their homes had been
sprayed with insecticide and only one woman had been
taking chemoprophylaxis during pregnancy.
Malaria was confirmed by microscopy or RDT in 92.6%
(25/27) of the inpatients. P. falciparum was the cause of
malaria for 84% (21/25) of the pregnant women, while
two (8%) had P. vivax and two (8%) had mixed infection
with  P. falciparum and  P. vivax. Eight (29.6%) of the
admitted pregnant women had severe malaria (severe
anaemia, cerebral malaria) based on WHO criteria [23].
Of the 20 patients whose haemoglobin results were
recorded in the medical records, 12 had anaemia, five had
severe anaemia, and three were not anaemic. P. falciparum
was responsible for severe malaria in seven of eight
women, while the last had a mixed infection. All admitted
pregnant women were treated with parenteral or oral qui-
nine, arteether or artesunate with excellent responses;
none died.
Discussion
There was a relatively low prevalence of malaria among
pregnant women attending ANCs and delivering in the
study site hospitals in Jharkhand. Previous studies of MIP
in India found similar to higher prevalence rates, ranging
from 1.4% to 20% [12,24,25] However, these studies
focused on pregnant women who were febrile or had a
recent history of fever and thus may have had a selection
bias towards higher malaria rates. This approach, targeting
malaria diagnostic and treatment for symptomatic preg-
nant women, is consistent with India's National Vector
Borne Disease Control Programme guidelines [5]. In con-
trast, all pregnant women were evaluated in the current
study, including those who were asymptomatic. The low
prevalence of malaria, especially in the urban and semi-
urban study sites, suggests that these areas have low rates
of malaria transmission and, therefore, there is a potential
risk of outbreaks. Malaria was responsible for about one-
fifth of all hospitalizations of pregnant women at the
three study sites, suggesting that malaria, especially when
caused by P. falciparum, is responsible for a substantial
portion of serious illness requiring hospital admission for
pregnant women in this region.
Malaria occurred more commonly in women in rural
areas and those who were in their first or second preg-
nancy, as has been seen in studies of MIP in sub-Saharan
Africa [26]. The higher prevalence at the rural sites may be
due to higher transmission, less availability of preventive
measures such as ITNs and IRS, and limited access to anti-
malarial drugs. Pregnant women in urban areas may have
better access to prophylactic or therapeutic anti-malarial
drugs through private practitioners and other community
sources. However, the majority of study participants had
not taken an anti-malarial for treatment during the past
week or at any time during their pregnancy.
Overall, there was a substantial burden of anaemia among
pregnant women. While the proportion of pregnant
women suffering from severe anaemia was relatively small
(~4% in the ANC cohort), there was a significant associa-
tion with malaria. Among women in the DU cohort, there
was no association between parasitaemia and severe anae-
mia. The lack of an association with severe anaemia can be
potentially attributed to the smaller sample size in the DU
study cohort. Although none of the associations was sig-
nificant, adverse maternal and birth outcomes including
LBW, prematurity, stillbirth, and gestational hypertension
all occurred more commonly in pregnant women with
parasitaemia. Despite the low frequency of MIP, the large
population of Jharkhand, nearly 22 million people [27],
means that there are nearly 100,000 women at risk for
Table 6: Prevalence of adverse birth outcomes by presence 
versus absence of placental parasitaemia among pregnant 
women enrolled
Placental Parasitaemia
Present
n† (%)
Absent
n† (%)
Low birth weight 4/15 (26.7%) 137/657 (20.9%)
Preterm birth 2/15 (13.3%) 37/656 (5.6%)
Stillbirth 2/17 (11.8%) 28/686 (4.1%)
Gestational hypertension 4/17 (23.5%) 195/695 (28.1%)
Median (range) Median (range)
Birth weight 2,500 (2,100-3,900) 2,700 (1,300-4,500)
Gestational age 38 (36-40) 38 (34-42)
†Denominators vary because the neonate had to be born alive to be 
weighed and receive a Ballard score. Additionally, twin gestations and 
women whose placentas were not examined for parasitaemia were 
excluded from analysis of birth outcomes.
* Gestational hypertension defined as systolic blood pressure > 140 
mmHg or diastolic blood pressure > 90 mmHg.Malaria Journal 2009, 8:210 http://www.malariajournal.com/content/8/1/210
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malaria-associated complications based on the 1.8% prev-
alence we observed in the ANC population and assuming
that 25% of the population are women of child-bearing
age. Consistent with this hypothesis, a recent re-evalua-
tion of the worldwide burden of malaria in pregnant
women suggested a much higher burden of disease in the
Asia-Pacific region than previous estimates [28].
The EMCP was active in both Ranchi and Gumla Districts
until 2005 when the program ended. The low prevalence
of malaria among pregnant women in the current study
might have resulted from enhanced detection and treat-
ment of symptomatic individuals in the community
through personnel trained by this program. However, the
very low rate of ownership of ITNs suggests that this com-
ponent of the EMCP has not effectively reached this vul-
nerable population although it was encouraging to find
that many households had bed nets and that they were
used on a regular basis. The enhanced provision of ITNs
and their regular retreatment are cornerstones of the
EMCP [5,16]. Their notable absence among the large
cohort of pregnant women in this study, despite both
study districts having recently participated in this program
and the EMCP guidelines which prioritized ITN delivery
to pregnant women and children, suggests that
approaches for ITN distribution and enhancing commu-
nity awareness about the importance of their use need to
be addressed. Given the challenges of re-impregnating
bednets, the use of long-lasting ITNs would be preferable.
Despite its existence as an official guideline at the time,
chloroquine was almost never used for prevention of MIP.
Although chloroquine resistance has been rising in India
[2,5], this drug was recommended for malaria prophylaxis
in pregnant women in high risk areas at the time of the
study [29]. This recommendation has since been discon-
tinued. An alternative approach that is commonly used in
Africa is intermittent preventive treatment of pregnant
women (IPTp) with sulphadoxine-pyrimethamine [30].
Nonetheless, since the intensity of transmission and the
prevalence of malaria in pregnant women in Jharkhand
are lower than in many areas in sub-Saharan Africa, there
does not appear to be an urgent need to implement the
use of IPTp. A top priority in India, as a first step, should
be improved availability and use of ITNs by pregnant
women. If this step alone proves inadequate, then an
alternative strategy to IPTp that might be appropriate is
the use of intermittent screening and treatment in preg-
nant women. In this approach pregnant women are
screened for malaria parasitaemia at each antenatal visit
with either RDTs or blood smears. Treatment for malaria
is then provided only if the test is positive. This strategy
could potentially reduce the burden of MIP while limiting
the potential for anti-malarial resistance to develop due to
the widespread use of drugs for chemoprophylaxis. This
strategy would be especially effective in urban areas of
Jharkhand as 85% of pregnant women have at least one
ANC visit and 65% have three or more visits [18]. In con-
trast, this approach would be less useful in rural areas of
the state because only 53% of pregnant women have at
least one ANC visit and only 27% have three or more.
One major limitation of this study is that the cross-sec-
tional surveys were facility-based. Since a great part of the
malaria burden is thought to occur in marginalized,
remote tribal populations, the findings in this study may
not be generalizable to all areas and populations within
the state of Jharkhand. In addition, because this was a
cross-sectional rather than a longitudinal study, the actual
burden of MIP in this region may have been underesti-
mated. Thus, the study design did not allow for an under-
standing of the natural history of parasitaemia in
pregnant women or the frequency of malaria attacks dur-
ing the course of gestation. The use of placental smear in
this study instead of histopathology might have underes-
timated the burden of malaria since histopathology is
more sensitive in identifying placental malaria [20,21].
Finally, there is limited information on the use of RDTs
for diagnosing placental malaria [31,32]. Since these tests
detect antigen, it is possible that they may be detecting
malaria antigen in the placenta from chronic or past infec-
tions and thus may not conclusively demonstrate the pres-
ence of acute placental malaria.
Conclusion
Given the large at-risk population in this malaria-endemic
region of India, there is a need to enhance ITN use for the
prevention of MIP. Fortunately, there is already a culture
of bed net use. If ITNs become more widely available, they
would likely be acceptable to pregnant women barring
any problems with their perception of risk associated with
the chemicals used to treat the nets. Since the retreatment
of ITNs presents many logistical challenges, future efforts
should focus on the provision of long-lasting ITNs. An
additional challenge will be to increase their availability
and to make them affordable for Indians living below the
poverty line. There should be a focus on improving case
management of symptomatic pregnant women, and eval-
uating the efficacy and effectiveness of the intermittent
screening and treatment strategy. IPTp does not appear to
be a rational choice for reducing the burden of MIP, and
chloroquine prophylaxis may not be effective due to ris-
ing resistance and, in any case, is not being implemented
in Jharkhand. This requires enhancing the availability and
use of diagnostic tests including RDTs and ensuring the
availability of safe and effective drugs for the treatment of
pregnant women with malaria.
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